
RebelBio
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
RebelBio is SOSV’s London based pre-seed venture capital program. It invests in BioTech, HealthTech & Life Sciences.
Investor Profile
RebelBio has made 128 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Seed (67%)
- Convertible Note (23%)
- Pre Seed (9%)
- Series Unknown (1%)
Country Focus
- Ireland (28%)
- United States (19%)
- United Kingdom (14%)
- Canada (11%)
- Austria (10%)
- France (4%)
- Spain (3%)
- Chile (2%)
- India (2%)
- Mexico (2%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Food And Beverage
- Pharmaceutical
- Sustainability
- Agriculture
- Life Science
- Biopharma
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.